FDA Approves JOURNAVX™ (suzetrigine),: A First-in-Class Non-Opioid Analgesic for Acute Pain
Time to read: 01:09. The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine) 50 mg oral tablets, the first non-opioid analgesic in a new class of pain management drugs for moderate to severe acute pain in adults.
